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Case Report:
IgE-Mediated Hypersensitivity After Ibuprofen Administration
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Abstract. Although many immunoglobulin-related drug sensitivities have been described, there is a paucity 
of reports regarding IgE-related drug sensitivities. Here we describe a case of a patient who demonstrated 
IgE-mediated sensitivity to ibuprofen. 
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Case Report
A 78-yr-old man presented to the emergency room 
with occipital headache, confusion, drowsiness, 
and fever of acute onset. These symptoms began 15 
min after he had ingested ibuprofen, prescribed to 
treat arthralgia. The patient had no photophobia 
but complained of neck stiffness. He had no history 
of sore throat, cough, shortness of breath, diarrhea, 
or dysuria. He had a traumatic brain injury 15 yr 
earlier, due to a car accident. The injury consisted 
of a small subdural acute hematoma in the left 
hemisphere, with no skull fracture. At that time he 
was admitted to a hospital for observation lasting 
one week. The patient experienced total clinical 
recovery without medications or surgery.  
 During the past 5 months, the patient had 
experienced 3 episodes of meningitis without an 
identified cause. Various possible causes, such as 
CSF fistulas, infections, connective tissue disorders, 
and malignancy had all been investigated and 
excluded. The patient was taking bisoprolol for 
cardiac failure. He had no known food or drug 
allergies; his social history was unremarkable.
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 On neurological examination the patient was 
lethargic and was oriented neither to time or place. 
He had normal language, cranial nerve, and motor 
functions, but he displayed neck rigidity and 
bilateral Babinski signs. He was normotensive and 
febrile. Physical examinations of his other organ 
systems were normal.
 Laboratory tests revealed leukocytosis (13.3 x 
103 clls/mm3) with neutrophil predominance and 
increased concentration of serum C-reactive protein 
(9.35 mg/dl). An extensive panel of other laboratory 
tests was unremarkable, except for a highly elevated 
concentration of serum immunoglobulin E (IgE) 
of 1099 µg/ml (reference range <170 µg/ml). Urin-
alysis, blood cultures, and urine cultures were 
negative. Cerebrospinal fluid (CSF) analysis 
revealed a normal cell count but elevated protein 
(0.98 g/L) and glucose levels. CSF cultures grew no 
organisms. Electrocardiogram showed no acute 
changes and chest X-ray showed no evidence of an 
infiltrate. Computed tomogram (CT) and magnetic 
resonance imaging (MRI) of the head were 
unremarkable. 
 The patient’s medical records documented that 
3 episodes of aseptic meningitis had occurred 
within the past 5 months. At least 2 of the episodes 
were associated with ibuprofen ingestion. In the 3 
prior episodes of meningitis, serologic tests for 
362
Lyme disease, herpes, anti-nuclear antibodies, ds-
DNA, anti-SSA, anti-SSB, and rheumatoid factor 
were all negative.
 The patient was treated symptomatically 
during his hospital stay. His mental status and 
neurologic findings improved within 48 hr and he 
became afebrile. A subsequent assay of his serum 
IgE level dropped to normal. The patient was 
discharged from the hospital with a presumptive 
diagnosis of aseptic meningitis caused by ibuprofen-
induced hypersensitivity. The patient was advised 
to avoid taking ibuprofen or other nonsteroidal 
anti-inflammatory drugs (NSAIDs) in the future.
 
Discussion
Exposures to NSAIDs, particularly ibuprofen, have 
occasionally been linked to aseptic meningitis. 
Several case reports exist on this topic [1,2] but few 
have looked at its association with serum IgE titers. 
In the present study, upon initial examination our 
patient had an extremely elevated level of serum 
IgE. Although the diagnosis of drug-induced 
aseptic meningitis (DIAM) relies heavily on 
exclusion criteria [2], the clinical signs and CSF 
findings may vary [3]. The main categories of 
causative agents include NSAIDs, antimicrobials, 
and vaccines [3]. Possible mechanisms have been 
described for DIAM, including direct irritation of 
the meninges by intrathecal administration of the 
drug, and type III or type IV hypersensitivity 
reactions to the drug [3]. DIAM is treatable by 
withdrawal of the specific drug in question [3].
 In our patient with an extremely elevated 
serum IgE level, it would have been advisable to 
check the IgE specificity to ibuprofen by an enzyme 
linked immunosorbent assay (ELISA). Anania et al 
[4,5] measured specific IgE levels in cases of drug 
allergy and found the ELISA test to be a useful aid 
in confirming the diagnosis. Another confirmative 
approach for diagnosis would have been an oral 
challenge, but unfortunately the patient was lost to 
follow-up. Serum IgE levels had not been measured 
during our patient’s prior episodes of aseptic 
meningitis. Nonetheless, in light of the 3 episodes 
of aseptic meningitis that occurred following 
ibuprofen administration, we speculate that our 
patient had DIAM.
 Our patient did not display CSF pleocytosis, 
often described with neutrophil predominance in 
patients with DIAM, but he did have an elevated 
CSF protein level and negative cultures, which are 
also commonly observed [6]. Ibuprofen-induced 
meningitis is most often seen in patients with 
systemic lupus erythematosis (SLE), Sjogren’s syn-
drome, and mixed connective tissue diseases, 
although reports in previously healthy individuals 
have also been published [1,7,8]. SLE, an auto-
immune disease characterized by the production of 
pathogenic autoantibodies to nucleoproteins and 
DNA, may be caused by anti-DNA antibodies and 
deposition of these immune complexes in the 
kidneys [9]. Toll-like receptors, cytokines, and Fc 
receptors expressed by plasmacytoid dendritic cells 
may also play a role in the pathogenesis of SLE [9]. 
Patients with mixed connective tissue disease, as 
well as those with SLE, may be at risk for developing 
reactions to ibuprofen [7].  
 The mechanism of NSAID-induced aseptic 
meningitis has not been definitely established. 
However, several mediators of inflammation and 
immediate hypersensitivity (type I response) have 
been implicated in neurologic diseases [10]. 
Evidence corroborating this theory is that (a) the 
symptoms are not dose-dependent, (b) the rapidity 
of symptoms increases on subsequent re-exposure, 
and (c) the symptoms resolve upon discontinuation 
of the agent, as seen in our patient. Although the 
cardinal signs of an allergic reaction were absent in 
our patient, facial edema and/or conjunctivitis have 
been reported in 25% and rash in 22% of patients 
with NSAID-induced aseptic meningitis [11].
 Although IgE responses that are manifested as 
neurological reactions to NSAIDs have not been 
reported, there have been reports of other systemic 
manifestations, including cutaneous, respiratory, 
and anaphylactoid reactions [12-14]. Furthermore, 
the possible presence of an IgE-mediated allergic 
response to ibuprofen poses another mechanism for 
drug-induced meningitis. Elevated levels of IgE 
have been described in neurologic diseases including 
neurofibromatosis [15], stiff person syndrome [16], 
tuberculous meningitis [17], and meningo-
encephalitis due to Angiostrongylus cantonensis [18]. 
Meningitis has also been reported as an uncommon 
complication of hyper-IgE syndrome [19,20], 
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suggesting a possible relationship that warrants 
further evaluation. Garty et al [21] reported that 
patients with hyper-IgE syndrome have an increased 
risk of opportunisitc fungal infections such as 
cryptococcal meningitis.
 Antigen-specific IgE has been shown to be a 
mechanism of anaphylaxis in an animal model of 
multiple sclerosis [22] and in a systemic anaphylactic 
reaction to glatiramer acetate (GA), with the 
presence of IgE anti-GA antibodies [23]. In 
humans, there appears to be an association between 
ibuprofen-DIAM and diseases of the connective 
tissue, such as systemic lupus erythematosus [3]. 
IgE-mediated mechanisms have been associated 
with other diseases of the CNS, such as Parkinson’s 
disease [24]. Hunot et al [24] reported that Fc 
epsilon RII/CD23 is expressed in both astroglial 
and microglial cells of Parkinsonian patients and is 
not detectable in control subjects. 
 It is possible that our patient had an underlying 
undiagnosed immune dyscrasia. In that case, it 
might be that IgE production was a byproduct of 
improper antigen processing or a reaction to 
ibuprofen as a superantigen. Superantigens are 
considered to exacerbate autoimmune inflammation 
through expansion of autoreactive T cells [25]. An 
immune response to staphyloccocal superantigens 
in myelitic patients with atopic diathesis and 
elevated IgE levels has been reported [25].
 Another mechanism by which elevated IgE 
levels associated with ibuprofen administration 
might cause aseptic meningitis is molecular 
mimicry. Molecular mimicry has been proposed as 
a hypothesis to explain the pathogenesis of multiple 
sclerosis [26]. Molecular mimicry occurs when 
peptides from pathogens share sequence or 
structural similarities with self-antigens [26]. In 
our patient, exposure to some pathogen for 
meningitis and/or IgE antibodies might mimic a 
specific CNS antigen, leading to initiation of 
disease when later challenged by a nonspecific 
trigger (ibuprofen). However, molecular mimicry 
alone may not be able to induce disease [26]. It has 
been reported that antigenic mimicry may be a 
consequence of paratope-specific modulations and 
that it is not solely dependent on the properties of 
the epitope [27].
 In summary, we report an unusual case of a 
patient with a presumptive ibuprofen-induced 
allergic response that was manifested as meningitis. 
Ibuprofen seems the main culprit of NSAID-
induced aseptic meningitis; however, sulindac, 
naproxen, and diclofenac are some of the other 
commonly used agents that have been implicated 
[28]. A careful history of drug usage should be 
taken from patients presenting with meningitis, 
particularly when the cause is unclear and CSF 
cultures are negative. NSAID-induced aseptic 
meningitis appears to be rare, but its actual 
incidence is probably underreported, in view of the 
large number of people who consume NSAIDs. 
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